what are the risks of glp-1 drugs & They Do GLP-1 Drugs and Eating Disorders:
Description
Jiang, Y
Using pharmacological agents with cardiovascular and renal benefits, including reninangiotensin system inhibitors and sodium-glucose cotransporter-2 inhibitors, is paramount
Complementary Therapies in Clinical Practice, 22 , 4450
Until more information becomes available and out of an abundance of caution, alternative medications should be used while nursing
If you want the most aggressive weight loss possible Retatrutide leads the field at 24-29% weight loss in trials
PMID: 39980336
